Visualisation And Early Prediction Of ROS-mediated Treatment Response In Liver Cancer By A Novel Nanoplatform
Funder
National Health and Medical Research Council
Funding Amount
$334,224.00
Summary
Change of tumour microenvironment has potential to serve as an early predictor of drug efficacy. This proposed project aims to develop a new technology to accurately measure tumour microenvironment during treatment, and to explore the correlation between this potential predicator and tumour growth. This technology would significantly improve the patient prognosis by revealing non-response to chemotherapeutics early and allowing the timely administration of alternative therapies.
Anti-metastasis Therapy Via Nanoparticle Mediated Drug Delivery
Funder
National Health and Medical Research Council
Funding Amount
$835,199.00
Summary
Most cancer deaths are caused by tumours that have spread to other vital organs, a process called metastasis. The common treatment for metastatic disease is chemotherapy, but the amount given is limited by toxicity to the patient. In this project, we are developing a way of delivering the therapies only to tumour cells, thereby sparing normal tissues. We are using nanoparticles that have a molecule on their surface that directs the therapy directly to tumour cells.
Rationally Designed Targeted Core Shell Nano-Construct For Improved Anticancer Effects And Enhanced Bone Fracture Healing In Breast Cancers Metastasised To Bone
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
The main objective of the project is to develop and evaluate a single therapeutic system comprising chemotherapeutic as well as bone fracture healing agent, which will overcome the drawbacks of the conventional treatment for skeletal bone metastasised breast cancers. This therapeutic system will specifically accumulates in the tumour sites and release the chemotherapeutic enabling anticancer effects, followed by the slow release of bone fracture healing agent results in healing of fractures.